Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives

Area of Science:

• Ophthalmology
• Genetics
• Pharmacology

Background:

• Cystinosis is a rare genetic disorder causing cystine crystal accumulation.
• Ocular manifestations, specifically corneal crystal deposition, are severe in cystinosis.
• Topical cysteamine is the sole effective treatment for ocular cystinosis.

Purpose of the Study:

• To review challenges and advances in cysteamine drug delivery systems (DDSs) for ocular cystinosis.
• To explore analytical determination methods and stability strategies for cysteamine formulations.
• To discuss potential future therapeutic alternatives for cystinosis.

Main Methods:

• Review of scientific literature on cysteamine DDSs for ocular cystinosis.
• Analysis of research on hydrogels, nanowafers, and contact lenses for sustained cysteamine release.
• Examination of methods for improving cysteamine formulation stability and analytical determination.

Main Results:

• Limited pharmaceutical investment and cysteamine instability necessitate novel DDSs.
• Development of sustained-release systems like hydrogels, nanowafers, and contact lenses is ongoing.
• Advancements in analytical methods and formulation stabilization strategies are crucial.

Conclusions:

• New DDSs are essential to improve patient adherence and treatment comfort for ocular cystinosis.
• Continued research into stable, effective cysteamine delivery is vital.
• Exploring alternative therapeutic strategies may offer future treatment options for cystinosis.